Predictive Factors of Cloxacillin Susceptibility in Primary Bacterial Spinal Infection.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 38710111.
- Also identified by DOI 10.1177/21925682241251814 and PMC identifier 11571538.
- Licence recorded as CC BY-NC-ND.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Study DesignPrognostic study.ObjectivesThe objective of this study is to identify predictive factors for cloxacillin susceptibility in spinal infections.MethodsA retrospective analysis was conducted using data from January 1, 1997, to December 31, 2021. The study included patients presenting with back pain and either a positive bacterial culture from the spine or radiological evidence of spinal infection (spondylodiscitis and/or epidural abscess) along with positive bacterial blood culture.ResultsAmong 171 patients (127 males, 44 females), 53.2% had <i>Staphylococcus</i> isolates, with 40.4% showing cloxacillin resistance. Lower globulin levels (<33.5 g/L), recent hospitalization within 90 days, and residence in an old age home predicted gram-positive bacteria with cloxacillin resistance and gram-negative bacteria as causative organisms (<i>P</i><.05). The 30-day and 1-year all-cause mortality rates were 0% and 8.2%, respectively. Higher red cell distribution width (RDW >16.1%) and Charlson comorbidity index (CCI) scores predicted 1-year all-cause mortality (<i>P</i><.05). Intensive care unit admission was required for 9.9% of patients.ConclusionsThis study identified predictive factors for spinal infection by gram-positive bacteria with cloxacillin resistance and gram-negative bacteria. Patients with lower globulin levels (<33.5 g/L), recent hospitalization within 90 days, or residency in an old age home upon admission should avoid standalone cloxacillin therapy and consider antibiotics with gram-negative coverage. Higher RDW (>16.1%) and CCI scores were associated with increased 1-year all-cause mortality. These findings contribute to treatment decision-making and improving patient outcomes in spinal infections.